Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

CnogaCare

Request full access

Developing noninvasive medical devices

Pardes Hana - Karkur, IsraelFounded 2004Biotech & Life Sciences

About CnogaCare

Cnoga Medical Ltd., operating as CnogaCare, is a privately held medical device company established in 2004 by Dr. Yosef Segman, who currently serves as the Chairman and Chief Technology Officer. Dr. Segman, an electrical engineer with a Ph.D. from the Technion, has a background in developing algorithms for image processing, machine learning, and signal processing, which forms the technological foundation of the company. The company is headquartered in Or Yehuda, Israel, with a presence in Shanghai, China, and São Paulo, Brazil.

CnogaCare focuses on the development and manufacturing of non-invasive medical monitoring devices, aiming to shift the paradigm of patient care from reactive to proactive. The company has developed a proprietary technology that utilizes a real-time color image sensor and unique algorithms to measure a wide array of physiological parameters without the need for blood samples. This technology analyzes the color changes in a patient's finger to derive critical health data.

The company's product portfolio includes devices like the CoG™, TensorTip™, and VMLife™. These devices are designed for both personal and professional use, serving individuals managing chronic conditions at home as well as healthcare providers in clinical settings. The flagship product line offers non-invasive monitoring of up to 15 biomarkers, such as blood glucose, hemoglobin, hematocrit, blood pressure, and pulse. These devices connect to a secure cloud-based platform, allowing for continuous monitoring and data sharing with caregivers and medical professionals, thereby facilitating remote patient management and telehealth services.

CnogaCare's business model appears to be centered on the sale of these medical devices and potentially recurring revenue through its cloud-based data management platform. The company targets the digital health and remote patient monitoring markets, addressing the growing need for accessible and pain-free diagnostics for chronic diseases like diabetes and hypertension. CnogaCare has secured regulatory approvals, including the CE Mark in Europe, for its non-invasive glucometer and other devices, enabling its commercialization in numerous countries.

Source: Dealroom company data

CnogaCare in the Pardes Hana - Karkur ecosystem

Live from Dealroom

The CnogaCare office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

1 investor on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • BOE Technology Group
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇮🇱 Israel75%
🇧🇷 Brazil25%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about CnogaCare on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See CnogaCare on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.